LECANEMAB EARLY PHASE 3 DATA FOR MILD COGNITIVE IMPAIRMENT IN ALZHEIMER’S DISEASE – September 28, 2022
WHY IS THERE DUPLICATE INFORMATION IN THE EMR? – September 26, 2022
White House Announces 1.5 Billion (and MOre) to Fight Opioid Crisis – September 23,. 2022
FDA Rejects poziotinib for NSCLC – September 22, 2022
Novartis to take fingolimod patent case to Supreme Court – September 21, 2022
OPTIMAL COMBINATION THERAPY FOR HFPEF – September 20, 2022
Biden Declares “Pandemic is over” – September 19, 2022
WHO: COVID Pandemic end in sight – September 15, 2022
NOVARTIS WHISTLEBLOWER LAWSUIT DISMISSED – September 14, 2022
JOURNALS EXPAND DATA MANIPULATION QUERIES IN TEMPLE UNIVERSITY CARDIOLOGY RESEARCH – September 13, 2022
FDA TO REVIEW FIRST OTC BIRTH CONTROL PILL IN NOVEMBER – september 12, 2022
STUDY LOOKS AT CROSS-NEUTRALIZING CAPABILITIES OF COVID-19 ANTIBODIES – September 9, 2022
CHILDHOOD ADVERSITY SIGNIFICANTLY ASSOCIATED WITH ACCELERATED AGEING – September 7, 2022
UPDATE ON NEW COVID BOOSTERS: SHOULD YOU GET A SHOT AND WHEN? – SEPTEMBER 6,2022
ultra-processed foods Linked with colorectal cancer risk – September 2, 2022
CDC PANEL RECOMMENDS UPDATED COVID BOOSTERS – September 1, 2022
SOTORASIB Meets Primary Endpoint of Progression-Free Survival in KRAS G12C-Mutated NSCLC – August 31, 2022
TEXAS CONFIRMS FIRST US MONKEYPOX DEATH – August 30, 2022
Boosting Physical Activity May Lower Heart Faiure Risk – August 30, 2022
HIGHER-COST MEDICARE ADVANTAGE PLANs MAY NOT PROVIDE BETTER CARE – August 29, 2022
Rare Tomato Flu Outbreak in India – August 26, 2022
Moderna sues Pfizer/BioNTech for COVID vaccine Patent INfringement – August 26, 2022
BIVALENT RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE 85.7% EFFECTIVE IN OLDER ADULTS – August 25, 2022
NOVARTIS TO SEPARATE SANDOZ BUSINESS TO CREATE A STANDALONE COMPANY – AUGUST 25, 2022
NOVARTIS HALTS DOSING IN PHASE IIB VIBRANT-HD TRIAL OF BRANAPLAM IN HUNTINGTON’S DISEASE – August 24, 2022
DR. FAUCI TO RETIRE IN DECEMBER – August 23, 2022
MEAN INCUBATION TIME 3.42 DAYS (2.88-3.96 DAYS) FOR THE OMICRON VARIANT – August 22, 2022
UK TO OFFER LOWER DOSE OF MONKEYPOX VACCINE DUE TO SHORT SUPPLY – August 22, 2022
Dextromethorphan HBr -Bupropion HCl Approved for the Treatment of Major Depressive Disorder – August 19, 3033
Neurocognitive and Brain Structure Changes Associated With the Start of Tobacco Use in Children – August 18, 2022
Sanofi Halts Amcenestrant Clinical Development Program for Breast Cancer – August 17, 2022
Trodelvy Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer – August 16, 2022
WHO TO RENAME MONKEYPOX OVER STIGMATIZATION CONCERNS – August 15, 2022
XOFLUZA APPROVED TO TREAT INFLUENZA IN CHILDREN AGED FIVE YEARS AND OLDER– August 12, 2022
SOUND PLUS ELECTRICAL STIMULATION HAS POTENTIAL TO TREAT CHRONIC PAIN – August 11, 2022
New ‘Langya’ Virus Carried by Shrews Identified in China – August 10, 2022
poLIO VACCINES FOR CHILDREN IN LONDON AFTER MORE VIRUS FOUND – August 10, 2022
PFIZER AND VALNEVA START PHASE 3 STUDY OF LYME DISEASE VACCINE – August 9, 2022
GENETIC VARIENTS ASSOCIATED WITH CHILDHOOD-ONSET AND ADULTHOOD-ONSET HODGKIN LYMPHOMA – August 8, 2022
WHY IS INSULIN SO EXPENSIVE – August 5, 2022
WHITE HOUSE DECLARES MONKEYPOX A NATIONAL EMERGENCY – August 4, 2022
POSITIVE RESULTS FOR PATISIRAN IN PATIENTS WITH ATTR AMYLOIDOSIS AND CARDIOMYOPATHY – August 3, 2022
HIGHER-DOSE FLUOROQUINOLONES ASSOCIATED WITH SERIOUS ADVERSE EVENTS IN OLDER ADULTS WITH ADVANCED CKD– August 2, 2022
New York Encourages Vaccinations as Polio Identified in Wastewater – August 2, 2022
High Risk Individuial Should not wait for next-generation, Omicron-targeted vaccines – JUly 29, 2022
Pediatric Hepatitis Cases Linked to Adeno-Associated Virus 2 (AAV2) – July 28, 2022
DOJ Investigates Cassava for Alleged Falsified Data – July 27, 2022
CDC: MONKEYPOX NATIONALLY NOTIFIABLE DISEASE Effective August 1 – July 27, 2022
WHO DECLARES MONKEYPOX A GLOBAL EMERGENCY – JULY 23, 2022
COLORECTAL CANCER TUMORS BOTH HELPED AND HINDERED BY T CELLS – JUly 22, 2022
POLIO CASE IDENTIFIED IN NEW YORK – July 21, 2022
PEMBROLIZUMAB FAILS IN PHASE 3 LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA – juLY 20, 2022
CDC ADVISERS ENDORSE NOVAVAX COVID VACCINE – JULY 19, 2022
CDC: 3RD AND 4TH DOSE MRNA VACCINE OFFERED SUBSTANTIAL PROTECTION FOR ADULTS AGAINST OMICRON – JULY 18, 2022
PERJETA-BASED REGIMEN CONTINUES TO REDUCE RISK OF RECURRING HER2-POSITIVE EARLY BREAST CANCER – JULY 15, 2022
ANIMAL-TO-HUMAN DISEASES TRANSMISSION INCREASES 60% IN LAST DECADE – JUNE 14, 2022
EARLY PHYSICIAN FOLLOW-UP + COMPREHENSIVE TRANSITIONAL CARE DECREASES READMISSION RATES FOR AMI, CHF AND COPD – JULY 13, 2022
HHS GUIDANCE CLARIFYING THAT EMERGENCY MEDICAL CARE INCLUDES ABORTION SERVICES – JULY 13, 2022
NEW DRUG FOSTERS NERVE REPAIR AFTER INJURY – JULY 12, 2022
BMI, PHYSICAL FUNCTION, AND OSTEOARTHRITIS SEVERITY PREDICT SUCCESS OF KNEE REPLACEMENT – JULY 11, 2022
2023 MEDICARE PHYSICIAN FEE SCHEDULE OPEN FOR PUBLIC COMMENT – JULY 11, 2022
NEW UNIVERSAL FLU VACCINE OFFERS SUSTAINED PROTECTION AGAINST INFLUENZA B VIRUSES – JULY 8, 2022
WATER BIRTH AS SAFE AS STANDARD INTRAPARTUM CARE – JULY 8, 2022
US COVID-19 VACCINATIONS MAY HAVE PREVENTED ~ 27 MILLION INFECTIONS, 1.6 MILLION HOSPITALIZATIONS, AND 235 000 DEATHS – JULY 7, 2022
FDA AUTHORIZES PHARMACISTS TO PRESCRIBE PAXLOVID – JULY 6, 2022
GUT MICROBIOME ACTIVITY SUGGESTS TIME-RESTRICTED FEEDING COULD COMBAT OBESITY – JULY 6, 2022
CUREVAC FILES A PATENT LAWSUIT IN GERMANY AGAINST BIONTECH VACCINE – JULY 5, 2022
SANOFI MAKES 30 TREATMENTS AVAILABLE ON A NOT-FOR-PROFIT BASIS IN 40 LOWER-INCOME COUNTRIES – JULY 4, 2022
STARTING TODAY: MEDICAL DEBT BEING REMOVED FROM CREDIT REPORTS – JULY 1 2022
PTSD LINKED TO COGNITIVE DECLINE IN MIDDLE AGE WOMEN – JULY 1, 2022 1 IN 10 ADULTS MAY HAVE CHRONIC KIDNEY DISEASE– JUNE 30, 2022
REGULATING GREM1 PROTEIN ALTERS THE SPREAD OF PANCREATIC CANCER – JUNE 30, 2022
SANOFI US CAPS OUT-OF-POCKET COST OF INSULIN AT $35 FOR UNINSURED – JUNE 29, 2022
SATIVEX (JZP378) FAILED TO ACHIEVE THE PRIMARY ENDPOINT FOR MS – JUNE 29, 2022
OMICRON SUB-VARIANTS BA.4 AND BA.5 MAKE UP MORE THAN 50% OF US COVID CASES – JUNE 28, 2022
ASTELLAS AND SUTRO BIOPHARMA COLLABORATION ON ADVANCE NOVEL IMMUNOSTIMULATORY ANTIBODY-DRUG CONJUGATES – JUNE 28, 2022
ENHERTU RECOMMENDED FOR APPROVAL IN THE EU FOR HER2-POSITIVE METASTATIC BREAST CANCER – JUNE 27, 2022
SERUM TTR REDUCTIONS SEEN IN PHASE 1 TRANSTHYRETIN (ATTR) AMYLOIDOSIS TRIAL – JUNE 24, 2022
FDA ISSUES CLASS I RECALL OF VOLARA SYSTEM – JUNE 23, 2022
POLIO FOUND IN LONDON SEWAGE: UK DECLARES NATIONAL EMERGENCY – JUNE 22, 2022
FDA EXPANDS SKYRIZI APPROVAL TO CROHN’S DISEASE – JUNE 21, 2022
U.S. COURT OF APPEALS RULES AGAINST NOVARTIS PATENT APPEAL FOR MULTIPLE SCLEROSIS DRUG – JUNE 21, 2022
STATIN USE ASSOCIATED WITH SLOWER PROGRESSION OF ARTERIAL STIFFNESS – JUNE 20, 2022
BLACK AMERICANS AT INCREASED RISK FOR NSCLC – JUNE 20, 2022
FEDERAL TRADE COMMISSION VOTES UNANIMOUSLY TO INCREASE SCRUTINY OF PHARMACY BENEFIT MANAGERS– JUNE 17, 2022
CRENEZUMAB DID NOT SLOW OR PREVENT COGNITIVE DECLINE IN EARLY-ONSET ALZHEIMER’S – JUNE 16, 2022
US SUPREME COURT RESTORES BILLIONS IN MEDICARE REIMBURSEMENTS TO HOSPITALS – JUNE 15, 2022
BABY BOOMERS HAVE MORE CHRONIC HEALTH CONDITIONS THAN EARLIER GENERATIONS – JUNE 14, 2022
OMICRON SUB-VARIANTS BA.4, BA.5 ACCOUNT FOR 21% OF COVID VARIANTS IN US – JUNE 14, 2022
FDA GRANTS CLEARANCE TO TRACK PARKINSON’S DISEASE THROUGH APPLE WATCH – JUNE 13, 2022
STUDY IDENTIFIES SUBOPTIMAL CARE IN PEDIATRIC COMMUNITY-ONSET SEVERE BACTERIAL INFECTIONS – JUNE 13, 2022
NATIONAL EYE INSTITUTE RESEARCHERS IDENTIFY NEW GENETIC MACULAR DISEASE – JUNE 10, 2022
MAN-MADE EAR IMPLANT FUNCTIONS JUST THE SAME AS A NORMAL EAR– JUNE 9, 2022
OPTIMISM ASSOCIATED WITH LONGER LIFESPAN AND HIGHER LONGEVITY OVERALL – JUNE 8, 2022
BIOMARKERS ALLOWS PATIENTS 55 + WITH LOW-GRADE LUMINAL A-TYPE BREAST CANCER TO AVOID RADIATION THERAPY – JUNE 8, 2022
PANITUMUMAB + MFOLFOX6 SIGNIFICANTLY IMPROVED OVERALL SURVIVAL IN RAS WILD-TYPE METASTATIC COLORECTAL CANCER – JUNE 7, 2022
OMICRON SUB-VARIANTS BA.4 AND BA.5 ACCOUNT FOR ~ 13% OF US COVID Cases – JUNE 7, 2022
TAFINLAR AND MEKINIST SHRINK PEDIATRIC BRAIN TUMORS MORE THAN 11% – JUNE 6, 2022
HHS OIG WILL REVIEW FDA’S ACTIONS LEADING UP TO THE INFANT FORMULA RECALL BY ABBOTT – JUNE 3, 2022
GENETICALLY ENGINEERED T CELLS SHRINK PANCREATIC CANCER TUMOR – JUNE 2, 2022
PHASE 3 SKYLARK STUDY OF ZURANOLONE IN POSTPARTUM DEPRESSION MEETS ENDPOINTS – JUNE 2, 2022
FDA WITHDRAWS APPROVAL OF UMBRALISIB FOR LYMPHOMA – JUNE 1, 2022
ASSOCIATION BETWEEN DIET QUALITY, LONGEVITY. AND SUCCESSFUL AGING– JUNE 1, 2022
VAGUS NERVE STIMULATION PROMOTES RESOLUTION OF INFLAMMATION – MAY 31, 2022
FDA PLACES CLINICAL HOLD ON TADALAFIL TO OTC TRIAL – MAY 30, 2022
HEPATITIS A OUTBREAK LINKED TO ORGANIC STRAWBERRIES – MAY 30, 2022
CDC UPDATES MONKEYPOX VACCINE RECOMMENDATIONS – MAY 27, 2022
3 PCR TEST KITS FOR MONKEYPOX DEVELOPED – MAY 26, 2022
FMNL2 ACTIVITY MAYBE THE LINK BETWEEN ALZHEIMER’S AND CV DISEASE – MAY 26, 2022
AIR POLLUTION AND AGE RELATED MORTALITY RISKS – MAY 25, 2022
ETRASIMOD LEADS TO REMISSION IN PHASE 3 ULCERATIVE COLITIS STUDIES – MAY 24, 2022
USPSTF CONSIDERS ADDING CKD TO LIST OF PREVENTATIVE SCREENING – MAY 23, 2022
80 MONKEYPOX CASES CONFIRMED IN 11 COUNTRIES – MAY 20, 2022
CHILDHOOD CV RISK FACTORS PREDICT ADULT CARDIOVASCULAR EVENTS – MAY 20, 2022
CDC STRENGTHENS RECOMMENDATIONS AND ELIGIBILITY FOR COVID-19 BOOSTERS – MAY 20, 2022
MASSACHUSETTS PUBLIC HEALTH OFFICIALS CONFIRM CASE OF MONKEYPOX – MAY 19, 2022
EARLIER INTERVENTION FOR SEVERE ASYMPTOMATIC AORTIC STENOSIS REDUCES ALL CAUSE MORTALITY – MAY 18, 2022
EMERGING GENOMIC TEST ABLE TO DETECT MUTATIONS IN 500-PLUS CANCER-RELATED GENES – MAY 18, 2022
PAXLOVID USE JUMPED 315% OVER THE PAST FOUR WEEKS SAYS HHS – MAY 17, 2022
FDA AUTHORIZES COVID-19 BOOSTER FOR HEALTHY 5- TO 11-YEAR-OLDS – MAY 17, 2022
UPDATE ON MONKEYPOX CASES IN ENGLAND – MAY 16, 2022
PRE-APPROVAL INSPECTION ISSUES DELAY BIMEKIZUMAB APPROVAL FOR SEVERE PLAQUE PSORIASIS – MAY 13, 2022.
HUMAN VENTRICULAR PROGENITOR CELLS PROMOTE THE FORMATION OF NEW HEART TISSUE AFTER MI – MAY 13, 2022
GUT MICROBIOME COMPOSITION PREDICTIVE OF PATIENT RESPONSE TO STATINS – MAY 12, 2022
NATIONAL LOCKDOWN IN NORTH KOREA AS ‘FIRST’ COVID CASE REPORTED – MAY 12, 2022
TIRAGOLUMAB + TECENTRIQ FAILS TO MEET ENDPOINTS IN PHASE II TRIAL OF NSCLC – MAY 11, 2022
PFIZER TO ACQUIRE BIOHAVEN PHARMACEUTICALS FOR $11.6 BLN – MAY 10, 2022
YOUNGER CANCER PATIENTS ARE A HIGH-RISK FOR POOR OUTCOMES FROM COVID-19 INFECTION – MAY 9, 2022
HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED CVD RISK – MAY 9, 2022
GENDER SPECIFIC RISK FACTORS MAY PREDICT HEART ATTACKS IN YOUNG ADULTS – MAY 6, 2022
OMICRON RISKS OF HOSPITALIZATION AND MORTALITY ALMOST IDENTICAL TO OTHER VARIANTS – MAY 5, 2022
FDA GRANTS IMFINZI PLUS CHEMOTHERAPY PRIORITY REVIEW FOR LOCALLY ADVANCED OR METASTATIC BILIARY TRACT CANCER – MAY 4, 2022
PROCURE STUDY: THE IMPORTANCE OF GENE EXPRESSION PROFILE TESTING IN GUIDING TREATMENT DECISIONS FOR EARLY-STAGE BREAST CANCER – MAY 4, 2022
FDA APPROVES CUVRIOR™ FOR PATIENTS WITH STABLE WILSON’S DISEASE WHO ARE DE-COPPERED AND TOLERANT TO PENICILLAMINE– MAY 3, 2022
INSULIN NASAL SPRAY MAY IMPROVE BRAIN HEALTH, & PREVENT ALZHEIMER’S IN NON-DIABETICS – MAY 3, 2022
FDA DECLINES APPROVAL OF 2 CANCER MEDS TESTED IN CHINA– MAY 2, 2022
AMERICAN ACADEMY OF PEDIATRICS CALLS FOR ELIMINATION OF RACE-BASED MEDICINE– MAY 2, 2022
CDC REPORTS: FIRST US CASE OF HUMAN AVIAN INFLUENZA A(H5) – APRIL 29, 2022
CAMZYOS™ (MAVACAMTEN) APPROVED FOR SYMPTOMATIC CLASS II – III OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY – APRIL 29, 2022
PFIZER RESTARTS PHASE 3 CIFFREO GENE THERAPY TRIAL – APRIL 28, 2022
NEW MODEL PREDICTS PATIENTS WITH POOR LUNG CANCER OUTCOMES – APRIL 27, 2022
HUMAN CASE OF H3N8 BIRD FLU REPORTED IN HENAN CHINA – APRIL 27, 2022
POSITIVE PHASE 2 PEDIATRIC DATA FOR LYME DISEASE VACCINE CANDIDATE – APRIL, 26, 2022
NEKTAR CUTS 70% OF WORKFORCE – APRIL 26, 2022
DRUG-RESISTANT FORM OF ASPERGILLUS FUMIGATUS (ENVIRONMENTAL MOLD) CAPABLE OF INFECTING PEOPLE – APRIL 25, 2022
WAR IN UKRAINE DISRUPTS MULTIPLE SCLEROSIS DRUG DEVELOPMENT – APRIL 25, 2022
WHO: 1 DEATH AND 169 CASES OF PEDIATRIC HEPATITIS REPORTED IN 12 COUNTRIES – APRIL 24, 2022
THE DIFFERENCE BETWEEN LONG COVID AND PERSISTENT COVID – APRIL 22, 2022
CDC UPDATE ON PEDIATRIC HEPATITIS CASES OF UNKNOWN ORIGIN – APRIL 22, 2022
AMERICAN LUNG ASSOCIATION:137 MILLION AMERICANS LIVE WITH UNHEALTHY AIR POLLUTION – APRIL 21, 2022
WHITE HOUSE SENDING NATIONAL DRUG CONTROL STRATEGY TO CONGRESS – APRIL 21, 2022
BOEHRINGER INGELHEIM AND LILLY LAUNCH HEAR YOUR HEART™ TO EMPOWER WOMEN WITH HEART FAILURE – APRIL 20, 2022
FDA CITES CONCERNS OVER TEVA AND MEDINCELL’ S EXTENDED-RELEASE RISPERIDONE FOR SCHIZOPHRENIA – APRIL 20, 2022
ABBVIE ENDS COLLABORATION AGREEMENT WITH BIOARCTIC – APRIL 20, 2022
FDA DRAFT GUIDANCE ON FOOD ALLERGENS AVAILABLE FOR COMMENT – APRIL 19, 2022
ACHIEVING TREATMENT GOALS LIKELY EXTENDS IN LIFE EXPECTANCY IN TYPE 2 DIABETES – APRIL 18, 2022
WHO AND CDC LOOKING INTO RARE PEDIATRIC HEPATITIS – APRIL 17, 2022
NEKTAR AND BMS HALT STUDIES OF BEMPEGALDESLEUKIN + NIVOLUMAB IN CANCER – APRIL 15, 2022
TOP PHARMA COMPANIES BY REVENUE IN 2021 – APRIL 15, 2022
STUDY IDENTIFIES DIFFERENCE BETWEEN PFIZER AND MODERNA COVID VACCINE ANTIBODIES – APRIL 15, 2022
COMBINATION THERAPIES SHOW BETTER OUTCOMES FOR HR-POSITIVE, ERBB2-NEGATIVE MB – APRIL 14, 2022
2021 WAS THE DEADLIEST YEAR IN U.S. HISTORY – APRIL 13, 2022
FDA AND DEA WARNING: ONLINE PHARMACIES ILLEGALLY SELLING ADDERALL – APRIL 13, 2022
CHILDREN WITH BIRTH DEFECTS HAVE A HIGH RISK OF POST NEONATAL MORTALITY– APRIL 12, 2022
FDA LIFTS PARTIAL CLINICAL HOLD ON MDS AND AML MAGROLIMAB STUDIES – APRIL 12, 2022
LEBRIKIZUMAB + TOPICAL CORTICOSTEROIDS SHOWS SIGNIFICANT IMPROVEMENTS IN ATOPIC DERMATITIS – APRIL 11, 2022
CAR T-CELL THERAPY FOR SOLID TUMORS SHOWS EARLY EFFICACY – APRIL 11, 2022
FDA PARTIAL CLINICAL HOLD FOR TAKEAIM LYMPHOMA STUDY OF EMAVUSERTIB – APRIL 11, 2022
CMS LIMITS COVERAGE FOR BIOGEN’S ADUHELM TO CLINICAL TRIALS – APRIL 8, 2022
ANTI-PD-1 TISLELIZUMAB ACCEPTED BY EMA FOR REGULATORY REVIEW IN ESOPHAGEAL AND LUNG CANCERS – APRIL 8, 2022
COVID CASES RISING AGAIN IN THE US – INTERACTIVE STATE MAP – APRIL 7, 2022
ACADIA PHARMACEUTICALS TO SUBMIT TROFINETIDE FOR RETT SYNDROME TO FDA – APRIL 7, 2022
PER
SONALITY TRAITS OF SELF-MADE AND INHERITED MILLIONAIRES – APRIL 6, 2022
MEDICARE COVERS 8 OVER-THE-COUNTER COVID-19 TESTS PER MONTH – APRIL 5, 2022
PEOPLE WITH A STRONGER BELIEF IN EVOLUTION MORE LIKELY SUPPORTIVE OF SOCIAL AND RACIAL DIFFERENCES – APRIL 5, 2022
CDC HIRES OUTSIDE OFFICIAL FOR REVIEW – PLANS RESTRUCTURE – APRIL 5, 2022
NORMAN SHARPLESS STEPS DOWN AS DIRECTOR OF THE NATIONAL CANCER INSTITUTE– APRIL 4, 2022